WHO recommends two new drugs to treat patients with COVID-19  

The World Health Organization (WHO) recommended on Thursday two new drugs to treat patients with COVID-19, one for patients with critical diseaseand one for non-severe cases.

The first drug, baricitinib, is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis.

According to the WHO Guideline Development Group, it is “strongly recommended” for patients with severe or critical disease in combination with corticosteroids. More